Ajani JA, D’Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Korn WM, Leong S, Linn C, Lockhart AC, Ly QP, Mulcahy MF, Orringer MB, Perry KA, Poultsides GA, Scott WJ, Strong VE, Washington MK, Weksler B, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H (2016) GC, Version 3.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 14:1286–1312

Article  PubMed  Google Scholar 

Araki K, Kinoshita R, Tomonobu N, Gohara Y, Tomida S, Takahashi Y, Senoo S, Taniguchi A, Itano J, Yamamoto KI, Murata H, Suzawa K, Shien K, Yamamoto H, Okazaki M, Sugimoto S, Ichimura K, Nishibori M, Miyahara N, Toyooka S, Sakaguchi M (2021) The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis. J Mol Med (Berl) 99:131–145

Article  PubMed  CAS  Google Scholar 

Balcioglu O, Gates BL, Freeman DW, Hagos BM, Mehrabad EM, Ayala-Talavera D, Spike BT (2024) Mcam stabilizes a luminal progenitor-like breast cancer cell state via Ck2 control and Src/Akt/Stat3 attenuation. NPJ Breast Cancer 10:80

Article  PubMed  PubMed Central  CAS  Google Scholar 

Baselga J, Swain SM (2009) Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer 9:463–475

Article  PubMed  CAS  Google Scholar 

Braun AD, Mengoni M, Tuting T, Gaffal E (2025) MCAM expression facilitates melanoma-endothelial interactions and promotes metastatic disease progression. Exp Dermatol 34:e70059

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bresnick AR, Weber DJ, Zimmer DB (2015) S100 proteins in cancer. Nat Rev Cancer 15:96–109

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen Y, Sumardika IW, Tomonobu N, Kinoshita R, Inoue Y, Iioka H, Mitsui Y, Saito K, Ruma IMW, Sato H, Yamauchi A, Murata H, Yamamoto KI, Tomida S, Shien K, Yamamoto H, Soh J, Futami J, Kubo M, Putranto EW, Murakami T, Liu M, Hibino T, Nishibori M, Kondo E, Toyooka S, Sakaguchi M (2019a) Critical role of the MCAM-ETV4 axis triggered by extracellular S100A8/A9 in breast cancer aggressiveness. Neoplasia 21:627–640

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen Y, Sumardika IW, Tomonobu N, Winarsa Ruma IM, Kinoshita R, Kondo E, Inoue Y, Sato H, Yamauchi A, Murata H, Yamamoto K-I, Tomida S, Shien K, Yamamoto H, Soh J, Liu M, Futami J, Sasai K, Katayama H, Kubo M, Putranto EW, Hibino T, Sun B, Nishibori M, Toyooka S, Sakaguchi M (2019b) Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion. Cancer Lett 452:178–190

Article  PubMed  CAS  Google Scholar 

Fang S, Du S, Luo X, Qing X, Wang L, Ban Y, Song G, Yang Y, Wei W (2024) The role of the S100A8/S100A9 in gastric tumor progression. Sci Rep 14:23574

Article  PubMed  PubMed Central  CAS  Google Scholar 

Futami J, Atago Y, Azuma A, Putranto EW, Kinoshita R, Murata H, Sakaguchi M (2016) An efficient method for the preparation of preferentially heterodimerized recombinant S100A8/A9 coexpressed in Escherichia coli. Biochem Biophys Rep 6:94–100

PubMed  PubMed Central  Google Scholar 

Gohara Y, Kinoshita R, Tomonobu N, Jiang F, Matsunaga Y, Hashimoto Y, Honjo T, Yamamoto KI, Murata H, Ochi T, Komalasari N, Yamauchi A, Kuribayashi F, Sakaguchi Y, Futami J, Inoue Y, Kondo E, Toyooka S, Morizane S, Ishiko A, Morita S, Sagayama K, Nakao K, Sakaguchi M (2025) An S100A8/A9 neutralizing antibody potently ameliorates contact hypersensitivity and atopic dermatitis symptoms. J Invest Dermatol. https://doi.org/10.1016/j.jid.2025.01.007

Article  PubMed  Google Scholar 

Hibino T, Sakaguchi M, Miyamoto S, Yamamoto M, Motoyama A, Hosoi J, Shimokata T, Ito T, Tsuboi R, Huh NH (2013) S100A9 is a novel ligand of EMMPRIN that promotes melanoma metastasis. Cancer Res 73:172–183

Article  PubMed  CAS  Google Scholar 

Kinoshita R, Sato H, Yamauchi A, Takahashi Y, Inoue Y, Sumardika IW, Chen Y, Tomonobu N, Araki K, Shien K, Tomida S, Torigoe H, Namba K, Kurihara E, Ogoshi Y, Murata H, Yamamoto KI, Futami J, Putranto EW, Ruma IMW, Yamamoto H, Soh J, Hibino T, Nishibori M, Kondo E, Toyooka S, Sakaguchi M (2019) Newly developed anti-S100A8/A9 monoclonal antibody efficiently prevents lung tropic cancer metastasis. Int J Cancer 145:569–575

Article  PubMed  CAS  Google Scholar 

Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M, Smalley KS, Mahale A, Eroshkin A, Aaronson S, Ronai Z (2007) Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 11:447–460

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mannion AJ, Odell AF, Baker SM, Matthews LC, Jones PF, Cook GP (2023) Pro- and anti-tumour activities of CD146/MCAM in breast cancer result from its heterogeneous expression and association with epithelial to mesenchymal transition. Front Cell Dev Biol 11:1129015

Article  PubMed  PubMed Central  Google Scholar 

Miller SG, Hoh M, Ebmeier CC, Tay JW, Ahn NG (2024) Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. Mol Biol Cell 35:ar31

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ruma IM, Putranto EW, Kondo E, Murata H, Watanabe M, Huang P, Kinoshita R, Futami J, Inoue Y, Yamauchi A, Sumardika IW, Youyi C, Yamamoto K, Nasu Y, Nishibori M, Hibino T, Sakaguchi M (2016) MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-kappaB and ROS formation upon ligand binding. Clin Exp Metastasis 33:609–627

Article  PubMed  CAS  Google Scholar 

Sakaguchi M, Kinoshita R, Tomonobu N, Sakaguchi Y, Futami J, Yamauchi A, Murata H, Yamamoto KI, Takahashi T, Gohara Y, Ochi T, Jiang F, Komalasari N, Chen Y, Ruma IMW, Sumardika IW, Zhou J, Honjo T, Kuribayashi F, Sagayama K, Toyooka S, Kondo E, Inoue Y (2024) Enhanced design of pCMViR-TSC plasmid vector for sustainably high cargo gene expression in mammalian cells. In Vitro Cell Dev Biol Anim 60:1215–1227

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sakaguchi M, Watanabe M, Kinoshita R, Kaku H, Ueki H, Futami J, Murata H, Inoue Y, Li SA, Huang P, Putranto EW, Ruma IM, Nasu Y, Kumon H, Huh NH (2014) Dramatic increase in expression of a transgene by insertion of promoters downstream of the cargo gene. Mol Biotechnol 56:621–630

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sakaguchi M, Yamamoto M, Miyai M, Maeda T, Hiruma J, Murata H, Kinoshita R, Winarsa Ruma IM, Putranto EW, Inoue Y, Morizane S, Huh N-H, Tsuboi R, Hibino T (2016) Identification of an S100A8 receptor neuroplastin-β and its heterodimer formation with EMMPRIN. J Invest Dermatol 136:2240–2250

Article  PubMed  CAS  Google Scholar 

Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7–33

PubMed  Google Scholar 

Srikrishna G (2012) S100A8 and S100A9: new insights into their roles in malignancy. J Innate Immun 4:31–40

Article  PubMed  CAS  Google Scholar 

Sumardika IW, Youyi C, Kondo E, Inoue Y, Ruma IMW, Murata H, Kinoshita R, Yamamoto KI, Tomida S, Shien K, Sato H, Yamauchi A, Futami J, Putranto EW, Hibino T, Toyooka S, Nishibori M, Sakaguchi M (2018) Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 increases MCAM stability, which enhances S100A8/A9-mediated cancer motility. Oncol Res 26:431–444

Article  PubMed  PubMed Central  Google Scholar 

Tan P, Yeoh KG (2015) Genetics and molecular pathogenesis of gastric adenocarcinoma. Gastroenterology 149(1153–1162):e1153

Article  Google Scholar 

Tardif MR, Chapeton-Montes JA, Posvandzic A, Page N, Gilbert C, Tessier PA (2015) Secretion of S100A8, S100A9, and S100A12 by neutrophils involves reactive oxygen species and potassium efflux. J Immunol Res 2015:296149

Article  PubMed  PubMed Central  Google Scholar 

Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827–839

Article  PubMed  CAS  Google Scholar 

Wang L, Chang EW, Wong SC, Ong SM, Chong DQ, Ling KL (2013) Increased myeloid-derived suppressor cells in GC correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins. J Immunol 190:794–804

Article  PubMed  CAS  Google Scholar 

Wang Z, Xu Q, Zhang N, Du X, Xu G, Yan X (2020) CD146, from a melanoma cell adhesion molecule to a signaling receptor. Signal Transduct Target Ther 5:148